The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Sai Parenterals Ltd

Sai Parenterals Ltd

BSE 544742 · NSE SAIPARENT · ISIN INE0H9F01037 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹520.40

-0.10%

BSE close, 28 August 2026

Market cap

₹2,299.09 cr

4.4 cr shares · Micro cap

Free float

₹621.97 cr

as published

P/E · P/B

— · —

EPS — · BV —

FY25-26 rev / PAT

162.25 / 16.78

₹ cr, as filed

Filings, window

26

10 selected · 38%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹400.00 52-WK HIGH ₹705.00 ₹520.40 39% of range
Against 52-week high-26.2%
Against 52-week low+30.1%
Day change-0.10%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share—
Price / earnings—
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin31.77%
Net margin16.82%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 52.78 8.88 2.01 31.77% 16.82%
Mar-26 · Q 56.79 9.95 3.04 23.51% 17.52%
FY25-26 162.25 16.78 5.13 20.54% 10.34%

Quarter on quarter

Revenue, quarter on quarter
-7.1%
Net profit, quarter on quarter
-10.8%
Operating margin, quarter on quarter
+826 bps

Disclosure profile 26 filings in the window

0 median 17.0 p75 · 25 sector max 52 26 80th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

26 filings · 10 selected · busiest 2026-08-11

Filing rhythm · the twelve most recent

2026-08-202026-10-08

SelectedProcedural

Filings

26 in the window · 9 earlier on record

  1. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    RTA's Certificate

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 5 October 2026 ·

    Press Release

    Press Release / Media Release

    Media release about the acquisition.

    Company Update / Press Release / Media Release View filing →

  3. 1 October 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst / Institutional Investor meetings under Regulation 30 (read with Para A of Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) ....

    Company Update / Analyst / Investor Meet View filing →

  4. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    for the declaration of unaudited financial results for the quarter and half year ended 30th September, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 30 September 2026 ·

    Change in Management

    Change in Management

    Outcome of the Board Meeting

    Company Update / Change in Management View filing →

  6. 30 September 2026 ·

    Outcome

    Board Meeting Outcome for Board Meeting Appointment Of Mr.Ashwani Singh Bisht CS And Mr.Arvind As COO.

    Board Meeting Appointment of Mr. Ashwani Singh Bisht CS and Mr. Arvind as COO.

    Others / Outcome without intimation View filing →

  7. 10 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizers Report and Voting Results for the 25th Annual General Meeting held on 10th September, 2026.

    AGM/EGM / AGM View filing →

  8. 10 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 25th Annual General Meeting held on 10th September, 2026.

    AGM/EGM / AGM View filing →

  9. 25 August 2026 ·

    Press Release

    Press Release / Media Release

    Announcement under Regulation 30 (LODR)

    Company Update / Press Release / Media Release View filing →

  10. 25 August 2026 ·

    Order / Contract

    Award_of_Order_Receipt_of_Order

    Announcement under Regulation 30 (LODR)

    Company Update / Award of Order / Receipt of Order View filing →

  11. 25 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of schedule of Analyst/Institutional Investors Meeting scheduled to be held on 31st August, 2026

    Company Update / Analyst / Investor Meet View filing →

  12. 20 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication of Notice of 25th Annual General Meeting of the Comapny for FY2025-26.

    Company Update / Newspaper Publication View filing →

  13. 20 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of Newspaper Publication in Form PAS-1 for change or variation in the objects of utilisation of IPO Proceeds.

    Company Update / Newspaper Publication View filing →

  14. 19 August 2026 ·

    AGM / EGM

    Book Closure Intimation For 25Th Annual General Meeting

    Book closure intimation for 25th Annual General Meeting

    AGM/EGM / AGM View filing →

  15. 19 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report of the company for FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  16. 19 August 2026 ·

    AGM / EGM

    Notice Of 25Th Annual General Meeting

    Notice of 25th Annual General Meeting for the Financial Year 2025-26 scheduled to be held on 10th September, 2026.

    AGM/EGM / AGM View filing →

  17. 18 August 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript of Earnings Call held on 12th August, 2026 at 02:30 PM (IST) for Quarter 1 of FY 2026-27.

    Company Update / Earnings Call Transcript View filing →

  18. 12 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Audio Recording of the Earnings call held on 12th August, 2026

    Company Update / Analyst / Investor Meet View filing →

  19. 12 August 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation Q1 FY 2027

    Company Update / Investor Presentation View filing →

  20. 11 August 2026 ·

    Press Release

    Press Release / Media Release

    Press Release

    Company Update / Press Release / Media Release View filing →

  21. 11 August 2026 ·

    Other Update

    Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Statement on deviation or varition of funds

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  22. 11 August 2026 ·

    Change in Management

    Change in Management

    Announcement under Regulation 30 (LODR)- Change in Management

    Company Update / Change in Management View filing →

  23. 11 August 2026 ·

    Results

    Financial Results For The Quarter Ended 30.06.2026.

    Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.

    Result / Financial Results View filing →

  24. 11 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August, 2026.

    Outcome of Board Meeting held on 11th August, 2026 at the registered office of the company.

    Board Meeting / Outcome of Board Meeting View filing →

  25. 7 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    The Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August, 2026.

    Company Update / Analyst / Investor Meet View filing →

  26. 4 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Meeting Proposed To Be Held On 11Th August, 2026.

    Sai Parenterals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results ....

    Board Meeting / Board Meeting View filing →

RSS feed for Sai Parenterals Ltd · the 50 most recent filings